Suppressive drug combinations and their potential to combat antibiotic resistance

被引:59
|
作者
Singh, Nina [1 ]
Yeh, Pamela J. [1 ]
机构
[1] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, 621 Charles E Young Dr East, Los Angeles, CA 90095 USA
来源
JOURNAL OF ANTIBIOTICS | 2017年 / 70卷 / 11期
关键词
ESCHERICHIA-COLI; LEUKEMIA-CELLS; IN-VITRO; ANTAGONISM; EVOLUTION; AGENTS; MECHANISMS; THERAPY; VANCOMYCIN; PERSISTENCE;
D O I
10.1038/ja.2017.102
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Antibiotic effectiveness often changes when two or more such drugs are administered simultaneously and unearthing antibiotic combinations with enhanced efficacy (synergy) has been a longstanding clinical goal. However, antibiotic resistance, which undermines individual drugs, threatens such combined treatments. Remarkably, it has emerged that antibiotic combinations whose combined effect is lower than that of at least one of the individual drugs can slow or even reverse the evolution of resistance. We synthesize and review studies of such so-called 'suppressive interactions' in the literature. We examine why these interactions have been largely disregarded in the past, the strategies used to identify them, their mechanistic basis, demonstrations of their potential to reverse the evolution of resistance and arguments for and against using them in clinical treatment. We suggest future directions for research on these interactions, aiming to expand the basic body of knowledge on suppression and to determine the applicability of suppressive interactions in the clinic.
引用
收藏
页码:1033 / 1042
页数:10
相关论文
共 50 条
  • [31] Applications of Bioinformatics tools to Combat the Antibiotic Resistance
    Hemlata
    Tiwari, Archana
    2015 INTERNATIONAL CONFERENCE ON SOFT COMPUTING TECHNIQUES AND IMPLEMENTATIONS (ICSCTI), 2015,
  • [32] NEW AND ALTERNATIVE APPROACHES TO COMBAT ANTIBIOTIC RESISTANCE
    Gupta, Tania
    Varshney, Rajat
    Varshney, Ritu
    Sonkar, Balendri
    EVERYMANS SCIENCE, 2020, 55 (3-4): : 127 - 130
  • [33] The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
    Bugde, Piyush
    Biswas, Riya
    Merien, Fabrice
    Lu, Jun
    Liu, Dong-Xu
    Chen, Mingwei
    Zhou, Shufeng
    Li, Yan
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (05) : 511 - 530
  • [34] PFMDR1-A Potential Target to combat the Mutli Drug Resistance in Malaria
    Panda, Susanta Kumar
    Kumar, Amit
    HELIX, 2013, 3 : 337 - 340
  • [35] Potential and use of bacterial small RNAs to combat drug resistance: a systematic review
    Chan, Hung
    Ho, Jeffery
    Liu, Xiaodong
    Zhang, Lin
    Wong, Sunny Hei
    Chan, Matthew T. V.
    Wu, William K. K.
    INFECTION AND DRUG RESISTANCE, 2017, 10 : 521 - 532
  • [36] Acceleration and suppression of resistance development by antibiotic combinations
    Shingo Suzuki
    Takaaki Horinouchi
    Chikara Furusawa
    BMC Genomics, 18
  • [37] Acceleration and suppression of resistance development by antibiotic combinations
    Suzuki, Shingo
    Horinouchi, Takaaki
    Furusawa, Chikara
    BMC GENOMICS, 2017, 18
  • [38] Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review
    Kumar, Manoj
    Sarma, Devojit Kumar
    Shubham, Swasti
    Kumawat, Manoj
    Verma, Vinod
    Nina, Praveen Balabaskaran
    Devraj, J. P.
    Kumar, Santosh
    Singh, Birbal
    Tiwari, Rajnarayan R.
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [39] Single-cell microfluidics enabled dynamic evaluation of drug combinations on antibiotic resistance bacteria
    Li, Xiaobo
    Song, Yanqing
    Chen, Xiuzhao
    Yin, Jianan
    Wang, Ping
    Huang, He
    Yin, Huabing
    TALANTA, 2023, 265
  • [40] Combination of Selected PPI's With Antibiotics to Explore their Potential Role as Adjuvant to Combat Antibiotic Resistance
    LI, Juan
    Wang, Wei
    Javed, Mizna
    Buabeid, Manal
    Murtaza, Ghulam
    Wu, Zhao
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (09): : 1878 - 1884